Clinical Trial Update: Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 clinical trial evaluated haploidentical allogeneic transplantation with post-transplant regulatory T-cell infusion in several hematologic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Snippet

Sponsor: Everett Meyer | Conditions: Leukemia, Acute, Chronic Myelogenous Leukemia (CML) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-05-11